Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes, CLC Bio Ink Licensing Pact

NEW YORK (GenomeWeb News) – ImaGenes will provide its next-generation sequencing customers with a license to CLC Bio’s Genomics Workbench for sequence analysis applications under a new bundling agreement, CLC Bio said today.

ImaGenes Director of Bioinformatics and Services Steffen Henning said in a statement that the firm sought "a software platform which we could use to present our research results to our customers in an easy, coherent, and user-friendly way," and which would function with various next-generation sequencing platforms.

The bundling agreement enables ImaGenes to provide all of its customers who receive next-generation sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.